Concepedia

Mohamed A. Kharfan‐Dabaja

MA

Statistics

Publications

181

Citations

8.4K

H-Index

53

Active since

2002

Affiliations

Moffitt Cancer Center(Current)

Mayo Clinic in Florida

Medical College of Wisconsin

The University of Texas MD Anderson Cancer Center

Fred Hutch Cancer Center

Mohamed A. Kharfan‐Dabaja is an author at Moffitt Cancer Center specializing in medicine, hematology, and oncology.

ORCID

Top concepts

Publications per year

2002–2025

181

Publications

181

Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma

Michael R. Bishop, Michael Dickinson, Duncan Purtill et al. · New England Journal of Medicine · 2021 · 491 citations · Full text

Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors

Abraham S. Kanate, Alberto Mussetti, Mohamed A. Kharfan‐Dabaja et al. · Blood · 2015 · 271 citations · Full text

A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial

Mohamed A. Kharfan‐Dabaja, Michael Boeckh, Marissa B. Wilck et al. · The Lancet Infectious Diseases · 2012 · 229 citations · Full text

Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis

Nilanjan Ghosh, Reem Karmali, Vanderson Rocha et al. · Journal of Clinical Oncology · 2016 · 227 citations

Feasibility and correlates of arsenic trioxide combined with ascorbic acid-mediated depletion of intracellular glutathione for the treatment of relapsed/refractory multiple myeloma.

Nizar J. Bahlis, Jennifer McCafferty-Grad, Ileana Jordan-McMurry et al. · PubMed · 2002 · 190 citations

, , +19

1–5 of 181